Your session is about to expire
← Back to Search
Fecal Microbiota Transplant for Autism
Study Summary
This trial is testing whether fecal microbiota transplantation, following treatment with Vancomycin, can help improve social deficits and language delays in people with ASD.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot stop taking my diarrhea medication before the study.I am getting help for autism at school or in the community.I am getting help for autism at school or in the community.I am at least two years old.My medications have not changed in the last two months.I am at least two years old.I am a man and will use effective birth control during the study.I am not pregnant, nursing, or planning to become pregnant during the study.My medications have not changed in the last two months.I do not have any serious health issues affecting my brain function, like uncontrolled seizures.I have been diagnosed with cancer, but it's not a small, localized basal cell carcinoma.I cannot stop taking antibiotics not part of the study during the trial.I have had, or will have, surgery to remove my stomach or entire colon.I am HIV positive.I have Hepatitis B or C.I have been diagnosed with Autism Spectrum Disorder.
- Group 1: Autism Subjects
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is Fecal Microbiota Transplant a reliable procedure with no serious risks?
"The safety of Fecal Microbiota Transplant was assessed as 1 on our scale due to the limited data in Phase 1 trials that address both its efficacy and security."
Is this experiment enrolling participants at the present time?
"The latest update to clinicaltrials.gov indicates that this particular medical trial is no longer recruiting patients, as the research commenced on May 1st 2022 and was last revised on February 24th 2022. Although there are presently 278 other trials actively enrolling participants."
What outcomes is this research endeavor working to realize?
"This research project, with a duration of 52 Weeks, aims to track Serious Adverse Events. Additionally, the Autism Treatment Evaluation Checklist (ATEC), Childhood Autism Rating Scale 2 (CARS-2) and Shannon Diversity Index will be monitored to measure secondary objectives."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger